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Human T-cell leukemia virus type 1 (HTLV-1) Tax (Tax1) plays crucial roles in leukemogenesis in part
through activation of NF-κB. In this study, we demonstrated that Tax1 activated an NF-κB binding (gpκB)
site of the gp34/OX40 ligand gene in a cell type-dependent manner. Our examination showed that the
gpκΒ site and authentic NF-κB (IgκB) site were activated by Tax1 in hematopoietic cell lines. Non-
hematopoietic cell lines including hepatoma and ﬁbroblast cell lines were not permissive to Tax1-
mediated activation of the gpκB site, while the IgκB site was activated in those cells in association with
binding of RelB. However RelA binding was not observed in the gpκB and IgκB sites. Our results suggest
that HTLV-1 Tax1 fails to activate the canonical pathway of NF-κB in non-hematopoietic cell lines. Cell
type-dependent activation of NF-κB by Tax1 could be associated with pathogenesis by HTLV-1 infection.
& 2013 Elsevier Inc. All rights reserved.Introduction
Infection with human T-cell leukemia virus type1 (HTLV-1) causes
adult T-cell leukemia (ATL) and inﬂammatory disorders such as HTLV-
1 associated myelopathy/tropical spastic paraparesis and HTLV-1
associated uveitis (Hinuma et al., 1981; Osame et al., 1986; Poiesz
et al., 1980). HTLV-1 encodes Tax1, which has been shown to be
implicated in the pathogenesis of HTLV-1 associated disorders (Giam
and Jeang, 2007). Tax1 is a trans-acting transcriptional regulator that
exerts its function via cellular transcription factors mainly cAMP
responsive element binding protein (CREB), nuclear factor κB (NF-κB)
and serum responsive factor (SRF) (Ballard et al., 1988; Fujii et al., 1992;
Lenzmeier et al., 1998). Tax1 interaction with cellular transcription
factors leads to transcriptional changes in many cellular genes as well
as activation of HTLV-1 transcription (Lenzmeier et al., 1998; Ohtani
and Nakamura, 2002; Yoshida M., 2001; Zhao and Giam, 1992).
Previous studies demonstrated that activation of NF-κB by Tax1 isll rights reserved.
ra).
sity of Michigan, Ann Arbor,
Cancer Institute, Nationalclosely associated with development and maintenance of ATL (Akagi
et al., 1995; Ben-Neriah and Karin, 2011; Matsuoka and Jeang, 2007;
Qu and Xiao, 2011). Tax1 activates both the NF-κB canonical and non-
canonical pathways consisting of RelA with p50 and RelB with p52,
respectively (Harhaj and Harhaj, 2005; Xiao et al., 2001). Activation of
the canonical pathway results mainly from association of Tax1 with
the IKK complex, leading to inactivation of IκB by phosphorylation,
followed by translocation of the RelA/p50 complex to the nucleus
(Geleziunas et al., 1998; Jin et al., 1999). Tax1 is also able to directly
facilitate the transition of the precursor p100 into p52, thus promoting
translocation of the non-canonical pathway complex RelB with p52 to
the nucleus (Higuchi et al., 2007; Shoji et al., 2009). In the nucleus, NF-
κB binds promoter DNA elements to initiate or enhance transcription
of respective genes. The other member of the HTLV family is HTLV-2,
which also produces a trans-acting transcriptional molecule so-called
Tax2 (Ross et al., 1996). Tax2 does resemble Tax1 in terms of the ability
to activate NF-κB and differs from Tax1 in that Tax2 predominantly
activates the canonical NF-κB pathway (Higuchi et al., 2007; Shoji
et al., 2009).
The gp34 gene was ﬁrst identiﬁed to be a target of Tax1 in
human T cells (Miura et al., 1991; Tanaka et al., 1985). Since its
discovery, the gene product has been revealed as an OX40 ligand
(OX40L), a type II transmembrane member of the tumor necrosis
factor (TNF) superfamily, which is expressed on antigen presenting
T. Mizukoshi et al. / Virology 443 (2013) 226–235 227cells, endothelial cells and activated T cells under normal immune
conditions (Baum et al., 1994). OX40L interacts with OX40, a member
of the TNF receptor family, which is predominantly expressed in T cell
and delivers co-stimulatory signals implicated in expansion, survival
and homeostasis of T cells (Ishii et al., 2010). Among ATL cells and
HTLV-1 infected T cells, only T cells expressing Tax1 express OX40L
on their cell surface. We previously reported that the gp34 (OX40L)
gene promoter has an element capable of NF-κB binding (Ohtani
et al., 1998). The NF-κB binding (gpκB) site is, at least in part,
responsible for Tax1-mediated expression of OX40L on T cells. This
Tax1-mediated expression makes the interaction of OX40 with
OX40L possible in the same T cells. OX40 and OX40L interaction in
ATL development remains to be examined. Our preliminary results
indicate that the gpκB site in the OX40L promoter is somewhat
different from the classical NF-κB binding site represented by the NF-
κB binding site (IgκB site) of the immunoglobulin light chain gene
promoter. The gpκB site in the OX40L promoter fails to be activated in
the presence of Tax1 in the ﬁbroblast cell line REF52, in contrast to
activation in the T cell line Jurkat.
In this study, we wished to understand how Tax1 activated the
gpκB site in a cell type-dependent manner. Our results indicate
that Tax1 does not activate the canonical NF-κB pathway in non-
hematopoietic cell lines, suggesting involvement of Tax1 in T cell
pathogenesis.Results
Tax1 does not activate the gpκB site in non-hematopoietic cells
Tax1 activated the IgκB and gpκB sites in Jurkat cells (Fig. 1), as
shown previously (Ohtani et al., 1998). Unexpectedly, in REF52 cells,gp B Ig B gp B Ig B
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Fig. 1. Cell type-dependent activation of the gpκB site by Tax1. Cells were transfected wit
Jurkat, K562 and Raji cells were cultured for 48 h. Huh7, HepG2 and C-1300 cells were cul
was normalized to protein content. Data are means 7 SE.
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Po0.05.Tax1 did not activate the gpκB site, while the IgκB site was activated
(Fig. 1). We hypothesized that responses of the gpκB site to Tax1
might be cell lineage-dependent. To test this notion, more cell lines
of hematopoietic and non-hematopoietic lineages were used for
reporter assays with Tax1. Non-hematopoietic cell lines, the human
osteosarcoma cell line MG63, the human hepatoma cell lines Huh7
and HepG2, the human cervical cancer cell line HeLa, the human
embryonic kidney cell line 293T and the murine neuroblastoma cell
line C-1300 exhibited Tax1-mediated activation of the IgκB site, but
the gpκB site was not activated in response to Tax1 in those cell lines
(Fig. 1). A slight but not signiﬁcant activation of the gpκB site by Tax1
was observed in HeLa and 293T cells, however this activation may be
due to indirect effects of Tax1 (discussed later). Hematopoietic cell
lines, the human Burkitt's lymphoma cell line Raji and the human
myelogenous leukemia cell line K562, allowed activation of the gpκB
site by Tax1 similar to Jurkat (Fig. 1). These results suggest that Tax1
does not activate the gpκB site in non-hematopoietic lineage
cell lines.
In order to study cell type-dependent activation of the gpκB site
by Tax1, we examined effects of ectopic expression of NF-κB
subunits (RelA, p105/p50, RelB, p100/p52 and c-Rel) on the
activation of the gpκB site in non-hematopoietic cell lines. The
gpκB site was activated by overexpression of either RelA or p50
without Tax1 in REF52, MG63 and HeLa cells (Fig. 2A). Similarly
RelA-dependent activation was seen with the IgκB site (Fig. 2A).
Increased activation by RelA was dose-dependent (Fig. S1). Ectopic
expression of c-Rel slightly activated the gpκB site (Fig. 2A).
Introduction of RelB or p52 combination however did not change
reporter gene expression from the gpκB site, while the IgκB site
was activated by treatment with RelB (Fig. 2A and B). These results
suggest that the canonical pathway is closely associated with
activation of the gpκB sites in non-hematopoietic cells.gp B
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Fig. 2. Effects of NF-κB subunits on gpκB site activation. Expression plasmids for NF-κB subunits or Tax1 were transfected to REF52, HeLa and 293T cells along with the gpκB
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⁎
Po0.05.
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Based on these results, we assumed the possibility that Tax1
did not activate the canonical pathway in non-hematopoietic cell
lines and that the non-canonical pathway might be responsible for
Tax1-dependent activation of the IgκB site. The assumption was
examined by experiments with REF52 cells overexpressing the NF-
κB subunits. Interestingly, overexpression of the non-canonical
pathway subunit RelB alone or along with p52, a partner in the
non-canonical pathway, signiﬁcantly activated the IgκB sites in
REF52 cells in the absence of Tax1 (Fig. 2A and B). Consistent with
this, disruption of RelB or p52 by introduction of respective siRNA
signiﬁcantly reduced activation of the IgκB site by Tax1, while
siRNA for RelA or p50 did not show appreciable effect (Fig. 3).
HTLV-2, a human retrovirus close to HTLV-1, produces Tax2, which
is known to predominantly activate the canonical NF-κB pathway
(Matsumoto et al., 1997). Similar to Tax1, Tax2 activated both gpκB and
IgκB sites in Jurkat cells, while, in REF52 cells, the gpκB site was not
activated by Tax2 (Fig. 4A). Tax2 exhibited signiﬁcantly lower activa-
tion of the IgκB sites than Tax1 in REF52 cells (Fig. 4B). A chimera Tax
mutant (Tax1/2) between Tax1 and Tax2, in which the Tax1 (225–232)
region responsible for activation of the non-canonical pathway was
replaced with a region of Tax2 (225–232), has little ability to activate
the non-canonical pathway (Shoji et al., 2009). The effects of the Tax1/
2 mutant on activation of the gpκB and IgκB sites were close to those
of Tax2, rather than Tax1, in Jurkat and REF52 cells (Fig. 4). Theseresults strongly indicate the possibilities that the gpκB site is activated
by the canonical, but not non-canonical, pathway and that the
canonical pathway is scarcely activated by Tax1 in non-
hematopoietic cell lines.RelA and p50 are expressed in non-hematoietic cells
We therefore examined expression and localization of NF-κB
subunits in non-hematopoietic cells. Immunostaining and Western
blot analyses clearly showed that REF52, MG63 and HeLa cells
expressed RelA, p50, RelB and p52 (Fig. 5A–H). RelA was mainly
present in the cytoplasm, while p50 was in the nucleus and
cytoplasm (Fig. 5A–D). The ability of those subunits to bind κB sites
was examined by electrophoreitic mobility shift assay (EMSA). In
contrast to the cytoplasmic extracts which gave supershift bands
with anti-RelA antibody, nuclear extracts from REF52 cells with or
without Tax1 expression did not form complexes containing RelA
with the gpκB site and the IgκB site (Fig. 6A and B). Binding of p50
was seen with both nuclear and cytoplasmic extracts; nuclear
extracts from Tax1-expressing REF52 cells formed the most abun-
dant complex. Ectopic expression of RelA in REF52 cells induced its
complex formation with the gpκB site (Fig. 6C). Complexes contain-
ing RelA were also detected using nuclear extracts from REF52 cells
ectopically expressing p50. These results are consistent with repor-
ter assays. RelB, p52 and c-Rel were not included in complexes
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T. Mizukoshi et al. / Virology 443 (2013) 226–235 229formed with the gpκB site when nuclear extracts were prepared
from Tax1-expressing REF52 cells (Fig. S2).
lmmunoﬂuorescence staining conﬁrmed the results of EMSA.
Tax1 introduction did not appreciably alter localization of RelA
predominantly localized in the cytoplasm in those cells except for
HeLa cells (Fig. 5A, C and D). In HeLa cells after Tax1 transfection,
RelA was seen in the nucleus as well as the cytoplasm irrespective
of Tax1 expression. This RelA expression might be attributable to
Tax1-dependent paracrine mechanism, because HeLa cells even
without Tax1 expression expressed RelA in the nucleus as indi-
cated by arrowheads in Fig. 5D. The p50 molecule was mainly seen
in the peri-nuclear region. RelB was present in the cytoplasm
before introduction of Tax1 like RelA. In contrast to RelA, Tax1
facilitated the inﬂux of RelB to the nucleus. Immunostaining with
anti-p52 antibody detected p100/p52 mainly in the cytoplasmwithout Tax1 and in both the cytoplasm and nucleus with Tax1.
Western blot examination also showed that RelB and p52 were
seen in the nucleus after Tax1 was expressed, while RelA stayed in
the cytoplasm even after Tax1 introduction in REF52 and MG63
cells (Fig. 5E and G). HeLa cells showed RelA translocation to the
nucleus, as discussed before (Fig. 5H). In contrast, Jurkat cells
exhibited translocation of RelA, as well as RelB and p52, in a Tax1-
dependent manner (Fig. 5B and F).
RelA and p50 expressed in REF52 cells were examined for their
function by stimulation with tumor necrosis factor α (TNFα).
TNFα induced activation of the IgκB site in the luciferase reporter
assays in association with translocation of RelA from the cyto-
plasm to the nucleus and phosphorylation of IκBα potentially
leading to degradation (Fig. 5I–K). MG63 and HeLa cells also
showed TNFα-induced RelA translocation (Fig. 5G and H). These
T. Mizukoshi et al. / Virology 443 (2013) 226–235230results suggest that RelA/p50 is functional in those non-
hematopoietic cell lines.Tax1 induces RelB and p52 binding to the IgκB site in vivo
In order to examine the ability of the IgκB site to bind NF-κB
subunits in cells, we performed the chromatin immunoprecipita-
tion (ChIP) assays in REF52, MG63 and HeLa cells with or without
Tax1 expression (Fig. 7A, C and D). After reporter plasmid
transfection with or without the Tax1 expression plasmid, cells
were lysed and immunoprecipitated by anti-NF-κB subunit anti-
bodies. None of the antibodies used precipitated appreciable gpκB
and IgκB site DNA elements without Tax1 expression (Fig. 7A).
Immunoprecipitation with anti-RelB, anti-p52 and anti-p50 antibo-
dies detected the IgκB site with Tax1 expression. In addition, HeLa
cells showed RelA binding to the IgκB site (Fig. 7D). As expected, only
anti-p50 antibody precipitated the gpκB site in REF52 cells with Tax1
expression. Antibodies to RelA, RelB and p52 did not effectively
precipitate the gpκB site in REF52 cells. These results indicate that at
least REF52 and MG63 cells do not have the active form of the RelA/
p50 complex in the nucleus in the presence of Tax1. In Jurkat cells,
both the gpκB and IgκB sites were immunoprecipitated with all
antibodies used in a Tax1-dependent manner (Fig. 7B).Tax1(-) 
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luciferase reporter assays (I), IκBα phosphorylation in Western blotting (K) and RelA anDiscussion
The present study demonstrates that the gpκB site is activated
by HTLV-1 Tax1 in a cell type-dependent manner. Hematopoietic
cell lines Jurkat, Raji and K562 activated the gpκB site upon Tax1
expression, whereas the seven non-hematopoietic cell lines failed
to activate the gpκB site. One the other hand, the IgκB site was
activated by Tax1 in both hematopoietic and non-hematopoietic
cell lines used in this study. As overexpression of the canonical
pathway subunit RelA activated the gpκB in non-hematopoietic
cells, the gpκB unresponsiveness is presumably due to inactivation
of the NF-κB canonical pathway by Tax1 in those cell lines. These
results also suggest that the gpκB site is probably activated by the
canonical pathway, but not by the non-canonical pathway, in the
non-hematopoietic cell lines. Many NF-κB binding sites have been
identiﬁed, most of which are activated by the canonical and non-
canonical pathways. The gpκB site may be a unique case of NF-κB
responsive elements that may discriminate the canonical pathway
from the non-canonical pathway. Among three transcription factor
pathways, involving NF-κB, CREB and SRF, which are directly
activated by Tax1, Tax1-mediated NF-κB activation has been
studied extensively and intensively. This is because ATL cells,
including their derivative cell lines, carry constitutively active
NF-κB (Yoshida et al., 1982). Studies suggest a close link betweenTax1(-)
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Fig. 5. (continued)
T. Mizukoshi et al. / Virology 443 (2013) 226–235 231Tax1 and malignant transformation (Grossman et al., 1995;
Matsuoka and Jeang, 2007; Shoji et al., 2009). In fact, Tax1 mutants
lacking the ability to activate NF-κB show poor transforming
activity. HTLV-2 Tax2 activates NF-κB similar to Tax1, however
malignant transformation by Tax2 has rarely been reported
(Higuchi and Fujii, 2009).
In contrast to Tax1, Tax2 immortalizes primary T cells efﬁciently
(our unpublished observations). The efﬁcient immortalization by
Tax2 may be attributed to Tax2 speciﬁc effects such as activation of
nuclear factor of activaed T cells (NF-AT) (Niinuma et al., 2005). We
previously demonstrated that Tax1 scarcely induces production of IL-
2 in T cells (Mizuguchi et al., 2009). Our results in this study exhibited
different activation patterns of the NF-κB binding sites by Tax1 and
Tax2; for example, Tax2 activated the IgκB site less extensively thanTax1 in REF52 cells (Fig. 4). Taking account of the poor ability of Tax2
to activate the non-canonical pathway, this is somewhat unexpected.
The difference may be a result that NF-AT is activated by Tax2 but not
by either Tax1 or Tax1/2, and also the IgκB site may be responsive to
NF-ΑΤ. Similarly, in Jurkat cells, gpκB response to Tax2 was less than
that to Tax1 (Fig. 4). Tax1 activates the canonical and non-canonical
pathways in Jurkat cells, inducing full activation of NF-κB. Tax2 and
Tax1/2 predominantly activate the canonical pathway, presumably
resulting in reduced response of the gpκB site to Tax2, compared
with response to Tax1. The different effects of Tax1 and Tax2 on
activation of the κB sites may be closely associated with the
differences in pathogenesis by infection with HTLV-1 and HTLV-2.
These assumptions may raise the question why the gpκB site is
not capable of binding of RelB and p52 in non-hematopoietic cell
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T. Mizukoshi et al. / Virology 443 (2013) 226–235232lines. It is obvious that Tax1-expressing those cells contained
active non-canonical complex RelB/p52, because the IgκB site
recruited the RelB/p52 complex (Fig. 7A). However the gpκB site
did not show appreciable binding of RelB and p52. At this moment,
a solid answer to this question has not been found. Association of
RelB and p52 with the gpκB site may be dependent on RelA and
p50 binding to the site. This notion may be supported by the result
that all four subunits of NF-κB are associated with the gpκB site in
Tax1-expressing Jurkat cells (Fig. 7B). Further examination is
necessary to clarify this issue.
To gain insight into the mechanism accounting for inactivation
of the canonical pathway in non-hematopoietic cell lines, we
examined the expression of the canonical pathway subunits RelA
and p50. Both molecules were expressed in REF52 cells at a
protein level. Although p50 was present in the nucleus and able
to bind the gpκB site upon Tax1 expression, RelA was not found in
the nucleus even after Tax1 introduction (Figs. 5 and 7). EMSA
examination demonstrated complex formation of RelA and p50
with the gpκB site using cytoplasmic lysates, suggesting that the
functional complex of RelA and p50 is present in REF52 cells. The
gpκB site is capable of RelA/p50 binding. Since Tax1 has been
shown to activate the RelA and p50 complex by interaction with
IKKγ in the IKK complex (Harhaj et al., 1999; Jin et al., 1999b), we
further examined expression of IKKγ by immunostaining with
anti-IKKγ antibody. Our observations clearly showed that IKKγ was
present in REF52 cells (data not shown). These results imply that
an unknown mechanism inhibiting the activation of the canonical
pathway complex RelA and p50 may be present in non-
hematopoietic cell lines. This mechanism might be related to theprocess of translocation from the cytoplasm to the nucleus,
because RelA was not seen in the nucleus in Tax1 expressing cells.
Cell type-dependent activation of NF-κB by Tax1 is reminiscent
of Tax1-mediated activation of the transcription factor E2F. Tax1
activated E2F in hematopoietic cells, however REF52 cells showed
little effect of Tax1 on E2F function (Ohtani et al., 2000). Although
a cellular factor mediating Tax1-dependent activation of E2F is not
known, the Tax1 mutant without the ability to activate NF-κB is
also unable to activate E2F (Ohtani et al., 2000). In addition, we
observed that Tax2 lacked the ability to activate E2F (our unpub-
lished results). E2F plays critical roles, as a transcription factor, in
cell proliferation through progression of the G1 to S phase
transition in the cell cycle (Mizuguchi et al., 2011; Ohtani and
Nakamura, 2002). Collectively, development of cell transformation
by Tax1 may require activation of both the canonical and non-
canonical pathways, which are not associated with non-
hematopoietic cell lines and Tax2, respectively.
In summary, HTLV-1 Tax1 does not activate the canonical NF-κB
pathway in the non-hematopoietic cell lines used in this study and
the NF-κB binding site in the OX40L promoter does not respond to
the non-canonical pathway in those cells.Materials and methods
Cell culture
REF52, MG63, HeLa and 293T cells were cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 10% fetal
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Fig. 7. NF-κB binding to κB sites in vivo. Chromatin complexes were prepared from REF52 (A), Jurkat (B), MG63 (C) and HeLa (D) cells transfected with reporter plasmids and
pMT-2Tax. After sonication, immunoprecipitation was performed with the antibodies indicated. Precipitated DNA fragments were subjected to PCR with primers speciﬁc for
the gpκB and IgκB sites in plasmids. The PCR products were 369-bp and 449-bp in length for the gpκB and IgκB sites, respectively.
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cin (10 μg/ml). Huh7 and HepG2 cells were cultured in DMEM-
high glucose (D5796, Sigma-Aldrich) with 10% FBS and antibiotics
(Sainz et al., 2009; Wilkening et al., 2003). C-1300 cells were
cultured in RPMI1640 medium supplemented with 5% FBS and
antibiotics (Fukuhara et al., 1996). Jurkat, K562 and Raji cells were
cultured in RPMI1640 with 10% FBS and antibiotics (Karpova et al.,
2005; Lozzio and Lozzio,1979; Schneider et al., 1977). TNFα was
added to REF52 cell culture for 30 min at a concentration of 40 ng/
ml otherwise stated. Cells were cultured at 37 1C in humidiﬁed
atmosphere with 5% CO2 in air.Plasmids
The reporter plasmids used were pIgκB-Luc and pgpκB-Luc
carrying three tandem repeats of κB sites in the immunoglobulin
light chain (IgκB: 5' –GGGGACTTTCC–3') and gp34 (OX40L) (gpκB:
5'–GGGGAAATTCA–3') genes, respectively, in pGL3-Basic vector
(Promega) with the gp34 (OX40L) core promoter (from −31 to
+27) (Ohtani et al., 1998). Expression plasmids of NF-κB subunits
were R/C CMV RelA for RelA/p65, R/C CMV p50 for p50, R/C CMV
RelBM2 for RelB, pCM-p52 for p52, pCn100 for p100 and pEF/
c-Rel for c-Rel (Baker et al., 1990; Latimer et al., 1998; Nakayama
et al., 1992; Tripathi and Aggarwal, 2006; Yamaoka et al., 1996).
The Tax1 expression plasmids pMT-2Tax and pEFneoTax1, and the
expression plasmids for wild type Tax2B and a chimeric mutant of
Tax1 and Tax2 (Tax1/2) have been described previously
(Matsumoto et al., 1997; Shoji et al., 2009). The β-galactosidase
expression plasmid pCMV-β-gal was used as an internal control of
transfection (Gunning et al., 1987; Matsumoto et al., 1994).Antibody
Antibodies to NF-κB subunits (RelA, SC-372; p50, SC-114; RelB,
SC-19 and p52, SC-848), anti-C23 antibody (H-250), anti-IκBα
antibody (SC-371) and anti-β-tubulin antibody (H-235) were
purchased from Santa Cruz. Anti-Tax1 mouse monoclonal antibody
TAXY-7 is described elsewhere (Tanaka et al., 1991). Anti-phospho-
IκBα antibody (5A5) was obtained from Cell Signaling. Fluorescein
isothiocyanate (FITC)-conjugated anti-rabbit IgG antibody
(eBioscience) and Texas Red-conjugated anti-mouse IgG antibody
(Vector) were used for visualization.Luciferase reporter assay
REF52 and MG63 cells were transfected with 5 μg of plasmid
DNA in 2HEPES buffered saline with 0.25 M CaCl2 24 h after cell
plating in a 10 cm dish. Jurkat, K562 and Raji cells were transfected
with 5 μg of plasmid DNA in DEAE-dextran solution [5 mg/ml in
1 M Tris–HCl (pH 7.4)]. Cells were harvested for reporter assays
48 h post transfection. C-1300, Huh7, HepG2, HeLa and 293T cells
were transfected with 1 μg of plasmid DNA using Lipofectamine™
2000 (Invitrogen) and harvested 24 h after transfection. Luciferase
activity was measured with a luminometer (LB 9507, Lumat) using
the Luciferase Assay System (Promega) and the activity of lucifer-
ase was normalized to β-galactosidase activity which was mea-
sured by absorption at 410 nm, or to protein content which was
determined by absorption at 750 nm with a spectrophotometer
(DU 64, Beckman). Assays were performed at least three times in
triplicate. The means 7 SE are presented.
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REF52 cells was plated on a 12 well plate and incubated with
siRNA (Santa Cruz) for RelB (SC-36403), p52 (SC-36043), RelA (SC-
61876) and p50 (SC-156175) at a ﬁnal concentration of 10 nM in
Lipofectamine™ RNAiMAX (Invitrogen) at 37 1C for 6 h. Cells were
cultured in medium with 10% FBS and antibiotics for 24 h,
transfected with pIgκB-Luc along with pMT-2Tax in Lipofectamine
2000. Cells were further cultured for 24 h and harvested for
luciferase activity measurement.Electrophoretic mobility shift assay (EMSA)
Nuclear and cytoplasmic lysates were prepared from cells
transfected with or without the indicated expression plasmids as
described (Adachi et al., 1998). From each lysate, 5 μg protein were
incubated with [32P]-labeled probes containing κB binding (IgκB
and gpκB) sites in DNA-binding buffer [13 mM HEPES (pH 7.8), 8%
glycerol, 65 mM NaCl, 1 mM DTT, 0.15 mM EDTA and 1 μg of poly
(dI-dC)]. In supershift assays, antibodies (1 μg) were added 1 h
before probe addition. The reaction products were separated on 4%
polyacrylamide gels in 5TBE buffer [450 mM Tris (pH 8.0),
450 mM boric acid and 10 mM EDTA (pH 8.0)] for 4 h at 200 V.
Gels were dried and autoradiographed.Chromatin immunoprecipitation (ChIP) assay
Cells were ﬁxed in 10% formaldehyde solution for 15min at 37 1C.
Crosslinked cells were harvested, lysed in a buffer [50 mM Tris–HCl
(pH 8.1), 1% SDS and 5mM EDTA] containing 1 mM phenylmethylsul-
fonyl ﬂuoride (PMSF) and sonicated 6 times of 30 s at output 4 of Duty
80 (UD-201, Tomy). The supernatant liquid was collected by centrifu-
gation and incubated with dilution buffer [20mM Tris–HCl (pH 8.1),
2 mM EDTA,150 mMNaCl and 1% Triton X-100] containing PMSF with
2 μg of salmon sperm DNA, 20 μl of normal rabbit serum (Dako) and
45 μl of rProtein A Sepharose (GE Health Bio-Science) for 2 h at 4 1C.
After rProtein A Sepharose was removed from samples, 2 μg of
antibody (anti-RelA, anti-p50, anti-RelB or anti-p52 antibody) was
added to each sample and incubated on a rotating platform for 24 h at
4 1C. Salmon sperm DNA (2 μg) and 45 μg of rProtein A Sepharose
were added to each sample and incubated for 1 h at 4 1C. DNA
fragments were eluted, puriﬁed and subjected to PCR with speciﬁc
primers (IgκB site, forward primer, 5'–TGGAGCGGCCGCAATAAAATA–3',
reverse primer, 5'-GGGCGGAGAATGGGCGGAAACT-3' gpκB site, for-
ward primer, 5'-CGGGCCTCTTCGCTATTAG-3' reverse primer, 5'-
GCGCCGGGCCTTTCTTTATGTTTT-3'). PCR products were electrophor-
esed on 2% agarose gels.Western blotting assay
Cells transfected with or without pMT-2Tax were harvested for
preparation of nuclear and cytoplasmic lysates. Cells were lysed with
buffer A [10 mM HEPES (pH 7.8), 1.5 mM MgCl2, 10 mM KCl, 0.1% NP-
40, 1 mM DTT and 0.5 mM PMSF] and centrifuged to separate nuclei
from supernatants. The resultant supernatants were used as sources of
cytoplasmic lysates after addition of glycerol and KCl at ﬁnal concen-
trations of 20% and 100 mM, respectively. Nuclear lysates were
prepared by extraction from nuclei with buffer C [50 mM HEPES (pH
7.8), 420 mM KCl, 0.1 mM EDTA, 5 mM MgCl2, 2% glycerol, 1 mM DTT
and 0.5 mM PMSF]. Electrophoresis was performed with 20 μg
of protein on 9% polyacrylamide gels. Proteins were blotted into
membranes (AE-6667, Atto). Membranes were immunostained and
visualized with antibodies using Enhanced Chemi Luminescence (ECL)
(Amersham Biosciences).Immunoﬂuorescence staining
Cells were plated on cover glasses, ﬁxed with 10% paraformal-
dehyde in PBS, and permeabilized with 0.4% Triton X-100 in PBS.
Cells were incubated in 3% bovine serum albumin fraction V in PBS
for 30 min and further incubated with mouse anti-Tax1 mono-
clonal antibody (TAXY-7) at 5 μg/ml for 1 h followed by the
addition of Texas Red-conjugated anti-mouse IgG antibody. Anti-
RelA, anti-p50, anti-RelB and anti-p52 antibodies were used at
5 μg/ml with FITC-conjugated anti-rabbit IgG antibody. Cells were
examined with a laser scanning confocal microscope (FV10i,
Olympus).
Statistical analysis
Differences in means between samples and controls were
assessed for statistical signiﬁcance by the student's t-test. Values
less than 0.05 are taken statistically signiﬁcant.Acknowledgments
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